FDA NDC Directory · JSON-LD · Markdown

infliximab

NDC 69438-0005 · DRUG FOR FURTHER PROCESSING · LIQUID

Labeler / ManufacturerLonza Biologics Tuas Pte Ltd.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeLIQUID
Active ingredientsINFLIXIMAB-DYYB (120 mg/mL)
Marketing started20260526
Package count2

External sources

Source: openFDA. Public-domain (CC0).